Compounds > biguanides
Page last updated: 2024-11-08

biguanides and Graves Disease

biguanides has been researched along with Graves Disease in 1 studies

Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.

Graves Disease: A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kasperska-Czyzykowa, T1
Czech, W1
Sawicki, Z1
Woy-Wojciechowski, J1
ZuĊ‚awnik, W1

Other Studies

1 other study available for biguanides and Graves Disease

ArticleYear
[Thyroid function in diabetics treated with sulfonylurea and biguanides].
    Polskie Archiwum Medycyny Wewnetrznej, 1978, Volume: 59, Issue:3

    Topics: Adult; Biguanides; Diabetes Mellitus; Graves Disease; Humans; Hypoglycemic Agents; Hypothyroidism; M

1978